Godavari Biorefineries Secures Chinese Patent for Novel Anti-Cancer Molecule
Godavari Biorefineries Ltd., through its biotech arm Sathgen Therapeutics, has been granted a Chinese patent for its novel anti-cancer molecule HYDROXY-1,4-NAPHTHALENEDIONE.
Chinese Patent | 22/07/2025 | By Mrinmoy Dey | 250
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy